Table of Contents
Advances in Geriatrics
Volume 2015, Article ID 270657, 6 pages
http://dx.doi.org/10.1155/2015/270657
Research Article

Testing Van Gool’s Hypothesis: A Method to Predict Side Effects of Cholinesterase Inhibitors in Patients with Cellular Degenerative and Vascular Dementia

1Department of Clinical Neuropsychology, VU University, 1081 BT Amsterdam, Netherlands
2Department of Geriatrics, Albert Schweitzer Hospital, 3318 AT Dordrecht, Netherlands
3Faculty of Social Sciences, Leiden University, 2300 RB Leiden, Netherlands
4Department of Psychiatry and Psychotherapy, Ludwig-Maximilian University, 80539 Munich, Germany
5Hersencentrum, 1016 XW Amsterdam, Netherlands

Received 9 November 2014; Revised 10 May 2015; Accepted 25 May 2015

Academic Editor: Stavros Baloyannis

Copyright © 2015 Liza van Eijk et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. American Psychiatric Association, Diagnostic and Statistical Manual of Mental Disorders, American Psychiatric Association, Washington, DC, USA, 4th edition, 2000.
  2. V. T. Griffith, “Diagnose and treat mild to moderate Alzheimer's disease,” The Nurse Practitioner, vol. 27, no. 12, pp. 13–25, 2002. View at Google Scholar · View at Scopus
  3. M. Grothe, L. Zaborszky, M. Atienza et al., “Reduction of basal forebrain cholinergic system parallels cognitive impairment in patients at high risk of developing Alzheimer's disease,” Cerebral Cortex, vol. 20, no. 7, pp. 1685–1695, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. T. Erkinjuntti, G. Román, S. Gauthier, H. Feldman, and K. Rockwood, “Emerging therapies for vascular dementia and vascular cognitive impairment,” Stroke, vol. 35, no. 4, pp. 1010–1017, 2004. View at Publisher · View at Google Scholar · View at Scopus
  5. A. W. Lemstra, P. Eikelenboom, and W. A. van Gool, “The cholinergic deficiency syndrome and its therapeutic implications,” Gerontology, vol. 49, no. 1, pp. 55–60, 2003. View at Publisher · View at Google Scholar · View at Scopus
  6. G. Pepeu, M. G. Giovannini, and L. Bracco, “Effect of cholinesterase inhibitors on attention,” Chemico-Biological Interactions, vol. 203, no. 1, pp. 361–364, 2013. View at Publisher · View at Google Scholar
  7. D. M. Malone and J. Lindesay, “Cholinesterase inhibitors and cardiovascular disease: a survey of old age psychiatrists' practice,” Age and Ageing, vol. 36, no. 3, pp. 331–333, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. H. Kavirajan and L. S. Schneider, “Efficacy and adverse effects of cholinesterase inhibitors and memantine in vascular dementia: a meta-analysis of randomised controlled trials,” The Lancet Neurology, vol. 6, no. 9, pp. 782–792, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. S. S. Gill, G. M. Anderson, H. D. Fischer et al., “Syncope and its consequences in patients with dementia receiving cholinesterase inhibitors: a population-based cohort study,” Archives of Internal Medicine, vol. 169, no. 9, pp. 867–873, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. N. L. Graham, T. Emery, and J. R. Hodges, “Distinctive cognitive profiles in Alzheimer's disease and subcortical vascular dementia,” Journal of Neurology, Neurosurgery & Psychiatry, vol. 75, no. 1, pp. 61–71, 2004. View at Google Scholar · View at Scopus
  11. E. Scherder, Aging and Dementia. Neuropsychology, Motor Skills and Pain, VU University Press, Amsterdam, The Netherlands, 2011.
  12. R. Barber, P. Scheltens, A. Gholkar et al., “White matter lesions on magnetic resonance imaging in dementia with Lewy bodies, Alzheimer's disease, vascular dementia, and normal aging,” Journal of Neurology Neurosurgery and Psychiatry, vol. 67, no. 1, pp. 66–72, 1999. View at Publisher · View at Google Scholar · View at Scopus
  13. H. C. Chui, “Subcortical ischemic vascular dementia,” Neurologic Clinics, vol. 25, no. 3, pp. 717–740, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. S. Bagnoli, Y. Failli, I. Piaceri et al., “Suitability of neuropsychological tests in patients with vascular dementia (VaD),” Journal of the Neurological Sciences, vol. 322, no. 1-2, pp. 41–45, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. A. Dalvi, “Alzheimer's disease,” Disease-a-Month, vol. 58, no. 12, pp. 666–677, 2012. View at Publisher · View at Google Scholar